• BX Home
  • Pharmaceuticals Companies: News [Page 10]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

PHARMACEUTICALS COMPANIES

The phrase "Big Pharma" is often used to refer to pharmaceutical companies with revenue in excess of $3 billion, and/or R&D expenditures in excess of $500 million. It is these pharmaceutical companies that are shaping the future of medicine. This topic covers the latest news and views on the companies behind the pharmaceuticals

10 largest are Johnson and Johnson, Pfizer, Bayer, GlaxoSmithKline, Novartis, Sanofi-Aventis, Hoffmann-La Roche, Astra Zeneca, Merck & Co., Abbott Laboratories.


Pharmaceuticals Companies is part of Business Exchange, suggested by Henri TCHEN. This topic contains 1,251 news and 150 blog items. Read updated news, blogs, and resources about Pharmaceuticals Companies. Find user-submitted articles and reactions on Pharmaceuticals Companies from like-minded professionals.

News

Recent news on this topic.

Novartis: We're paying for reform without seeing benefitsmore

benefits of additional coverage have not yet hit.There's a timing issue there. Novartis (NVS) and other pharmaceutical...

Opinion: Kathleen Spitzermore

and Lexapro. The allegations were among a rash of government suits claiming that marketing to doctors common among drug...

Prescriptions for Supply Chain Successmore

Globalization and the age of integrated digital technology have been both a boon and a bane of multinational...

WSJ What's News Midday May 2, 2011more

what early DNA tests have to say about the man who orchestrated the 9-11 attacks; A couple of pharmaceutical companies...

Five of Dow���s Top 10 Stocks Likely to Keep Rising: John Dorfmanmore

high: Chevron earned 19 percent on stockholders��� equity last year. Pfizer Inc. ($21, up 20 percent). Buy.

The $600 Million Decoder Ringmore

Tomorrow it could apply similar steps to studying all manner of molecular creatures from RNA to ribosomes, giving...

Pfizer Chief Sees Growth Beyond Lipitormore

Pfizer's long-time research and development center, in Groton, Conn., up to Cambridge, Mass. Why? Mr. Read:...

Aust health needs anti-fraud laws: expertmore

major target for fraudulent corporate activities and Australia is unlikely to be immune with most of the major drug...

Glaxo's growth is not an accident: Andrew Witty, global CEOmore

India? An IP framework, which is not enforced or bureaucratically slow, is useless. Right now, even the Indian...

Slipstream: Data Privacy, Put to the Testmore

BIG OIL. Big Food. Big Pharma. To the catalog of corporate bigs that worry a lot of us little people, add this: Big...

Data Privacy, Put to the Testmore

BIG OIL. Big Food. Big Pharma. To the catalog of corporate bigs that worry a lot of us little people, add this: Big...

Professional Relations Excellence Outlined in New Best Practices, LLC ...more

leader in pharmaceutical research and consulting for 17 years; our clients include 48 out of the top 50 pharmaceutical...

Tata SMG's biz opportunities compendiummore

market with world-class connectivity, availability of skilled manpower, R&D centres and training institutes and...

Pacific Biosciences' $600 Million Decoder Ringmore

Tomorrow it could apply similar steps to studying all manner of molecular creatures from RNA to ribosomes, giving...

Show Us the Money, Drugmakersmore

have to be split between. The problem with increasing the dividend rather than repurchasing shares is that many...

Chart of the Day: Our Ballooning Healthcare Costsmore

our growth rate is still one of the highest too. No matter how much we pay our doctors, pharmaceutical companies,...

Chart: Our Huge Health Care Costsmore

our growth rate is still one of the highest too. No matter how much we pay our doctors, pharmaceutical companies,...

Europe's Drug Companies Turning Into Consumer Goods Groupsmore

Europe?s drug makers have again presented a mixed bag of results, with first-quarter updates underscoring how their...

4-Star Stocks Poised to Pop: AstraZenecamore

fact, AstraZeneca even sports a cheapish forward P/E of 8.2. That represents a slight discount to other big pharma...

UPDATE 3-Novo Nordisk profits rise, ups Victoza prospectsmore

billion in a Reuters poll. [ID:nLDE73P0LK] In contrast, first-quarter earnings from AstraZeneca (AZN.L REFORMS,...

US study blow for Roche and Novartismore

Extract not available.

Haridopolos: 'A mistake was made'more

using state money for the database. The House bill maintains that provision. The House's proposal also bans...

Pacific Biosciences' $600 Million Decoder Ringmore

Tomorrow it could apply similar steps to studying all manner of molecular creatures from RNA to ribosomes, giving...

Sanofi-Aventis profit slipsmore

Chris Viehbacher, referring to the drop off in revenues as patents expire on key products. Like other large...

UPDATE 2-Novo Nordisk profits beat forecastsmore

5.21 billion in a Reuters poll. [ID:nLDE73P0LK] In contrast, first quarter earnings from AstraZeneca (AZN.

Top Sources: Pharmaceuticals Companies

  • 247wallst.com
  • Reuters
  • BusinessWeek
  • online.wsj.com
  • bloomberg.com
  • International Herald Tribune
  • Mail Online UK
  • New York Times
  • clinicaltrialscongress.blogspot.com
  • MarketWatch

Most Active Users in this Topic

see all contributors in Pharmaceuticals Companies

Featured White Papers

Post a Job

Jobs in this Topic

Pharmaceutical Tech - Level 1 (Continuous Recruitment) Job Merck | West Point, PA
Posted: Apr 30
Project manager - Pharmaceutical Company Ei | Charlotte, NC
Posted: May 25
SVP, Pharmaceutical Market Research (Qual and Quant) Pharma Market Research Consultancy | Horsham, PA
Posted: May 21
Pharmaceutical Sales Representative AZQQTucsonEAST Biotech / Pharma Company | Tucson, AZ
Posted: May 28
Senior SAP SCM APO DP/SNP Consultant w/pharmaceutical Company ProSoft Technology Group | Irving, TX
Posted: May 9

Report comment contains invalid characters. ()
cancel
Search Cancel